Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Therapy by Jarrod Longcor
Introduction
Jarrod Longcor is an innovative inventor based in East Haven, CT (US). He has made significant contributions to the field of cancer therapy through his research and development of novel compounds. His work focuses on targeted cancer treatments that aim to improve patient outcomes.
Latest Patents
Jarrod Longcor holds a patent for "Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy." This patent discloses phospholipid ether (PLE) molecules and phospholipid-flavagline conjugates. The conjugate includes a PLE linked to a flavagline via a linker. The methods outlined in the patent provide innovative approaches to treating cancer and targeting drugs specifically to tumors or cancer cells in patients. He has 1 patent to his name.
Career Highlights
Jarrod Longcor is associated with Cellectar Biosciences, Inc., where he continues to advance his research in cancer therapies. His work at the company emphasizes the importance of targeted treatments that can enhance the effectiveness of existing therapies while minimizing side effects.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Jarrod Longcor's contributions to cancer therapy through his innovative patent demonstrate his commitment to improving treatment options for patients. His work is a testament to the potential of targeted therapies in the fight against cancer.